Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Foster

Showing results (191-200 of 205) with videos related to

Pageof 21
Sort By:
The American Journal of Psychiatry|July 1, 1988
A curriculum for education in geriatric psychiatryR S Marin, J R Foster, C V Ford, et al.
Journal of Clinical Pharmacy and Therapeutics|July 22, 2014
The rheumatoid arthritis susceptibility polymorphism PTPN22 C1858T is not associated with leflunomide response or toxicityA M Hopkins, C E O'Doherty, D J R Foster, et al.
Toxicology and Applied Pharmacology|August 26, 1998
The reproductive toxicity of molinate and metabolites to the male rat: effects on testosterone and sperm morphologyM K Ellis, A G Richardson, J R Foster, et al.
Basic & Clinical Pharmacology & Toxicology|July 6, 2021
Effect of Roux-en-Y gastric bypass on the pharmacokinetic-pharmacodynamic relationships of liquid and controlled-release formulations of oxycodoneLouise Ladebo, Ahmad Y Abuhelwa, David J R Foster, et al.
British Journal of Cancer|May 12, 2005
Plucked human hair as a tissue in which to assess pharmacodynamic end points during drug development studiesD R Camidge, K R Randall, J R Foster, et al.
European Journal of Clinical Pharmacology|September 18, 2007
Population pharmacokinetics of buprenorphine following a two-stage intravenous infusion in healthy volunteersMette L Jensen, David J R Foster, Richard N Upton, et al.
Biorxiv : the Preprint Server for Biology|January 13, 2025
T Lymphocyte-Specific Deletion of SHP1 and SHP2 Promotes Activation-Induced Cell Death of CD4+ T Cells and Impairs Antitumor ResponseConnor J R Foster, Jasper Du, Oscar Pundel, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 27, 2019
Pharmacometrics in Australasia-Twenty Years of Population Approach Group of Australia and New ZealandStefanie Hennig, Jacqueline A Hannam, Carl M J Kirkpatrick, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 14, 2025
T lymphocyte-specific deletion of SHP1 and SHP2 promotes activation-induced cell death of CD4<sup>+</sup> T cells and impairs antitumor responseConnor J R Foster, Jasper Du, Oscar Pundel, et al.
The Journal of Biological Chemistry|October 20, 2020
Quantitative phosphoproteomic analysis reveals involvement of PD-1 in multiple T cell functionsAnna S Tocheva, Michael Peled, Marianne Strazza, et al.
Pageof 21

Showing results (191-200 of 205) with videos related to

Sort By:
Pageof 21
The American Journal of Psychiatry|July 1, 1988
A curriculum for education in geriatric psychiatryR S Marin, J R Foster, C V Ford, et al.
Journal of Clinical Pharmacy and Therapeutics|July 22, 2014
The rheumatoid arthritis susceptibility polymorphism PTPN22 C1858T is not associated with leflunomide response or toxicityA M Hopkins, C E O'Doherty, D J R Foster, et al.
Toxicology and Applied Pharmacology|August 26, 1998
The reproductive toxicity of molinate and metabolites to the male rat: effects on testosterone and sperm morphologyM K Ellis, A G Richardson, J R Foster, et al.
Basic & Clinical Pharmacology & Toxicology|July 6, 2021
Effect of Roux-en-Y gastric bypass on the pharmacokinetic-pharmacodynamic relationships of liquid and controlled-release formulations of oxycodoneLouise Ladebo, Ahmad Y Abuhelwa, David J R Foster, et al.
British Journal of Cancer|May 12, 2005
Plucked human hair as a tissue in which to assess pharmacodynamic end points during drug development studiesD R Camidge, K R Randall, J R Foster, et al.
European Journal of Clinical Pharmacology|September 18, 2007
Population pharmacokinetics of buprenorphine following a two-stage intravenous infusion in healthy volunteersMette L Jensen, David J R Foster, Richard N Upton, et al.
Biorxiv : the Preprint Server for Biology|January 13, 2025
T Lymphocyte-Specific Deletion of SHP1 and SHP2 Promotes Activation-Induced Cell Death of CD4+ T Cells and Impairs Antitumor ResponseConnor J R Foster, Jasper Du, Oscar Pundel, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 27, 2019
Pharmacometrics in Australasia-Twenty Years of Population Approach Group of Australia and New ZealandStefanie Hennig, Jacqueline A Hannam, Carl M J Kirkpatrick, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 14, 2025
T lymphocyte-specific deletion of SHP1 and SHP2 promotes activation-induced cell death of CD4<sup>+</sup> T cells and impairs antitumor responseConnor J R Foster, Jasper Du, Oscar Pundel, et al.
The Journal of Biological Chemistry|October 20, 2020
Quantitative phosphoproteomic analysis reveals involvement of PD-1 in multiple T cell functionsAnna S Tocheva, Michael Peled, Marianne Strazza, et al.
Pageof 21